Evaluating the effectiveness of the Micra AV pacemaker
Official title: Cohorte Française Des Patients Implantés de Micra AV
Run by Paris Sudden Death Expertise Center · NCT05953558 · Data updated 2026-11-12
This study is testing how well the Micra AV leadless pacemaker works for people with atrioventricular block to see if it improves their quality of life and heart function.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 18 Years to 110 Years |
| Sex | All |
| Enrollment | 1000 (estimated) |
| Sponsor | Paris Sudden Death Expertise Center Academic / other |
| Locations | 1 site (Paris) |
| Status | Recruiting |
| Started | May 1, 2023 |
| Main results expected | November 1, 2023 |
| Study ends | December 31, 2027 |
| Registry record updated | July 20, 2023 |
| Trial ID | NCT05953558 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates for this study are patients who have undergone Micra AV implantation.
✕Probably not a fit
Patients who refuse consent will not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This observational study aims to assess the real-world effectiveness of the Micra AV leadless pacemaker in patients with atrioventricular block. The Micra AV utilizes an embedded accelerometer to synchronize ventricular pacing with atrial contractions, potentially expanding its use beyond traditional indications. The study will involve the first 1000 patients implanted with the device in France, collecting data on outcomes such as quality of life and effectiveness. The findings will help determine the practical benefits of this innovative pacing technology in everyday clinical settings.
Why it matters
Potential benefit: If successful, this study could improve the quality of life for patients with atrioventricular block by providing a safer and more effective pacing option.
How similar studies have gone: Previous randomized clinical trials have demonstrated the efficacy of the Micra AV, indicating a promising outlook for this observational study.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * All patients who underwent Micra AV implantation Exclusion Criteria: * Refusal of consent
Where it's running
-
Paris Cardiovascular Research Centre (AV-CESAR Investigators)
Paris, France Recruiting
Study contacts
- Principal investigator: Eloi Marijon, MD,PhD — Paris Sudden Death Expertise Center
- Study coordinator: Eloi Marijon, MD,PhD
- Email: eloi.marijon@inserm.fr
- Phone: +33662833848
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Observational study on a new type of implantable defibrillator
This study looks at a new type of implantable defibrillator to see how well it works in preventing sudden cardiac death in patients who are at high risk.
-
Registry of patients with Tetralogy of Fallot using implantable defibrillators
This study is creating a national registry to track adult patients in France with Tetralogy of Fallot who have implantable defibrillators, to better understand their health over time.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.